Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis

[1]  Boris Pasche,et al.  TGF-β: duality of function between tumor prevention and carcinogenesis. , 2014, Journal of the National Cancer Institute.

[2]  J. Raj,et al.  Preterm human milk contains a large pool of latent TGF-β, which can be activated by exogenous neuraminidase. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[3]  Y. Conley,et al.  The utility of breastmilk for genetic or genomic studies: a systematic review. , 2013, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[4]  C. Anders,et al.  Debate: The biology of breast cancer in young women is unique. , 2013, The oncologist.

[5]  J. Palmer,et al.  Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. , 2013, Journal of the National Cancer Institute.

[6]  E. Sauter,et al.  Differential expression of cancer-associated proteins in breastmilk. , 2013, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[7]  D. Anderton,et al.  Differential Expression of Cancer-Related Proteins in Paired Breast Milk Samples from Women with Breast Cancer , 2012, Journal of human lactation : official journal of International Lactation Consultant Association.

[8]  S. Salminen,et al.  Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk , 2012, Pediatric Research.

[9]  E. Sauter,et al.  Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy , 2012, BMC Cancer.

[10]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[11]  N. Kondo,et al.  Maternal psychosocial factors determining the concentrations of transforming growth factor‐beta in breast milk , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[12]  D. Anderton,et al.  Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy , 2011, Epigenetics.

[13]  S. Shukla,et al.  Transforming growth factor beta 2: a predictive marker for breast cancer. , 2011, Indian journal of experimental biology.

[14]  P. ten Dijke,et al.  TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis , 2011, Journal of Mammary Gland Biology and Neoplasia.

[15]  Gretchen L. Gierach,et al.  Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics , 2010, Breast Cancer Research and Treatment.

[16]  W. Oddy,et al.  A systematic review of the importance of milk TGF‐β on immunological outcomes in the infant and young child , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[17]  I. Penttila.  Milk-derived transforming growth factor-beta and the infant immune response. , 2010, The Journal of pediatrics.

[18]  M. Sherman,et al.  Qualitative age interactions in breast cancer studies: mind the gap. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L M Wakefield,et al.  TGF-beta3 and cancer: a review. , 2009, Cytokine & growth factor reviews.

[20]  L. Wakefield,et al.  Transforming Growth Factor-βs and Mammary Gland Involution; Functional Roles and Implications for Cancer Progression , 2009, Journal of Mammary Gland Biology and Neoplasia.

[21]  M. Sherman,et al.  Recent trends in breast cancer among younger women in the United States. , 2008, Journal of the National Cancer Institute.

[22]  D. Anderton,et al.  Potential of using breast milk as a tool to study breast cancer and breast cancer risk. , 2008, Future oncology.

[23]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[24]  D. Hume,et al.  Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. , 2007, Cancer research.

[25]  J. Monks.  TGFβ as a Potential Mediator of Progesterone Action in the Mammary Gland of Pregnancy , 2007, Journal of Mammary Gland Biology and Neoplasia.

[26]  C. Knabbe,et al.  TGF‐Beta Signaling in Breast Cancer , 2006, Annals of the New York Academy of Sciences.

[27]  D. Spandidos,et al.  Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. , 2006, Cancer letters.

[28]  L. Wakefield,et al.  The two faces of transforming growth factor β in carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Gibson,et al.  Variations in transforming growth factor beta in human milk are not related to levels in plasma. , 2002, Cytokine.

[30]  M. Barcellos-Hoff,et al.  TGF-beta biology in mammary development and breast cancer. , 2011, Cold Spring Harbor perspectives in biology.

[31]  S. Tomičić,et al.  Breast milk cytokine and IgA composition differ in Estonian and Swedish mothers-relationship to microbial pressure and infant allergy. , 2010, Pediatric research.

[32]  A. Moustakas,et al.  Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. , 2007, Biochimica et biophysica acta.

[33]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[34]  L. Wakefield,et al.  The two faces of transforming growth factor beta in carcinogenesis. , 2003, Proceedings of the National Academy of Sciences of the United States of America.